Alzheimer's and dementia weekly
Axona is a new medical food product for the clinical dietary management of mild-to-moderate Alzheimer's Disease (AD). Axona has been shown in randomized, placebo controlled clinical trials to safely improve cognitive function and memory in patients diagnosed with mild-to-moderate AD. It will be marketed as an adjunctive therapy to currently approved AD drugs. Axona will be administered under physician supervision and dispensed by prescription, in accordance with applicable FDA regulations.
Axona provides........read the whole article
Foe more dementia information, click here
For ASlzheimer's and dementia activities, click here